Puma Biotechnology (PBYI) Non Operating Income (2011 - 2026)

Puma Biotechnology (PBYI) has 16 years of Non Operating Income data on file, last reported at $401000.0 in Q1 2026.

• Quarterly Non Operating Income rose 155.93% year-over-year to $401000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$399000.0 (up 92.45% YoY) and the FY2025 annual result came in at -$1.5 million, up 77.91% from the prior year.
• Non Operating Income climbed to $401000.0 in Q1 2026, from $1000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $401000.0 in Q1 2026 to a low of -$15.3 million in Q4 2022.
• A 5-year average of -$2.4 million and a median of -$2.0 million in 2023 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income tumbled 539.73% — and 2026, when it jumped 155.93%.
• Tracing PBYI's Non Operating Income over 5 years: stood at -$15.3 million in 2022, then jumped by 86.99% to -$2.0 million in 2023, then jumped by 43.48% to -$1.1 million in 2024, then soared by 100.09% to $1000.0 in 2025, then soared by 40000.0% to $401000.0 in 2026.
• The last three Non Operating Income figures came in at $401000.0 (Q1 2026), $1000.0 (Q4 2025), and -$330000.0 (Q3 2025), per Business Quant data.